Iterum Therapeutics (ITRM) Soars 4.63% Awaiting FDA Decision - AInvest
4 days ago • Google News
Iterum Therapeutics PLC (ITRM)
US$ 1.6-2.44%
Price Chart
Key Statistics
Market Cap
$ 39.2M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
589.59K
52W High
$ 3.02
52W Low
$ 0.81
Dividend Yield
0.00%
Beta
2.82
Technicals
50-Day MA
0.9889
200-Day MA
1.3412
52 Week High
3.02
52 Week Low
0.808
About ITRM
Iterum Therapeutics plc, a pharmaceutical company, develops and commercializes treatments for drug resistant bacterial infections in Ireland, Bermuda, and the United States. The company offers ORLYNVA.
Employees
9
Headquarters
Dublin, Ireland
CEO
Mr. Corey N. Fishman
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg